Kashmeeri Mastura, Islam A N M Shamsul, Banik Palash Chandra
Department of Public Health & Hospital Administration NIPSOM Dhaka Bangladesh.
Department of Noncommunicable Diseases Bangladesh University of Health Sciences (BUHS) Dhaka Bangladesh.
Public Health Chall. 2025 Mar 19;4(1):e70013. doi: 10.1002/puh2.70013. eCollection 2025 Mar.
Palliative care aims to alleviate suffering and improve the quality of life for patients with life-limiting illnesses through effective pain management with opioids. Despite its global importance, opioid use in palliative care faces significant challenges, particularly in resource-poor settings like Bangladesh. In Bangladesh, opioid use is notably low, with disparities between urban and rural areas. Cultural stigmas, strict regulations, and inadequate healthcare provider training further obstruct effective pain management.
This study aims to explore the challenges healthcare providers face regarding opioid use in both hospital and home-based palliative care settings.
A descriptive cross-sectional study was conducted using face-to-face semistructured interviews with 135 licensed healthcare providers from August to September 2022.
The respondents, predominantly young (57% aged 20-39) and female (68.9%), primarily manage late-stage cancer patients (98.5%), with pain (100%) being the primary symptom treated. Morphine syrup is commonly used (68.1%), whereas oxycodone and buprenorphine are unavailable. Side effects such as deep sedation (43.7%) and addiction (34.1%) highlight the need for careful monitoring. Limited awareness (10.4%) of national opioid policies results in inconsistent practices ( = 0.001) and ( = 0.004). Prescribing restrictions (60.7%) and dispensing rights issues contribute to operational challenges, affecting patient access to pain management. Misconceptions about palliative care (32.6%) and inter-departmental non-cooperation (38.5%) hinder patient referrals ( = 0.001) and continuity of care.
Inconsistent awareness of opioid policies causes varied practices and attitudes. Addressing referral challenges and prescribing restrictions requires interdisciplinary solutions, enhanced education, better policy dissemination, and standardized guidelines for effective palliative care opioid management.
姑息治疗旨在通过使用阿片类药物进行有效的疼痛管理,减轻患有危及生命疾病患者的痛苦并提高其生活质量。尽管其具有全球重要性,但姑息治疗中阿片类药物的使用面临重大挑战,尤其是在孟加拉国等资源匮乏的地区。在孟加拉国,阿片类药物的使用明显较低,城乡之间存在差异。文化耻辱感、严格的法规以及医疗保健提供者培训不足进一步阻碍了有效的疼痛管理。
本研究旨在探讨医疗保健提供者在医院和居家姑息治疗环境中使用阿片类药物时所面临的挑战。
2022年8月至9月,对135名持牌医疗保健提供者进行面对面半结构化访谈,开展了一项描述性横断面研究。
受访者主要为年轻人(57%年龄在20 - 39岁)和女性(68.9%),主要管理晚期癌症患者(98.5%),疼痛(100%)是主要治疗症状。常用吗啡糖浆(68.1%),而羟考酮和丁丙诺啡无法获得。深度镇静(43.7%)和成瘾(34.1%)等副作用凸显了仔细监测的必要性。对国家阿片类药物政策的认识有限(10.4%)导致做法不一致(=0.001)和(=0.004)。处方限制(60.7%)和配药权问题导致操作挑战,影响患者获得疼痛管理。对姑息治疗的误解(32.6%)和部门间不合作(38.5%)阻碍了患者转诊(=0.001)和护理连续性。
对阿片类药物政策的认识不一致导致做法和态度各异。应对转诊挑战和处方限制需要跨学科解决方案、加强教育、更好地传播政策以及制定有效的姑息治疗阿片类药物管理标准化指南。